DEDHAM, Mass., Nov. 1 /PRNewswire/ -- Signet Laboratories, Inc., a pioneer in evidence-based medicine (EviMed), today announced the availability of its IVD P504s antibody, for the detection of prostate cancer.
P504s is useful in detecting prostate carcinoma in samples obtained from prostatectomies, prostate needle biopsies, and transurethral prostate resections. P504s shows strong cytoplasmic granular staining in prostate carcinomas.
P504s positively stains prostatic adenocarcinoma cells, premalignant lesions of the prostate, high-grade prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia. The P504s protein is expressed in malignant prostate tissues, and only very weakly, if at all in benign prostatic tissue -- the staining for each case being easily distinguishable.
According to Angela Thomas, IHC Product Manager for Signet Laboratories, "P504s is a highly sensitive and specific marker for prostate carcinoma with demonstrated use in detecting and clearly marking malignant tissues and atypical prostate biopsies. Signet is pleased to offer P504s to customers, expanding our product portfolio, and our prostate antibody panel."
About Signet Laboratories, Inc.
Signet Laboratories, Inc. is a pioneering evidence-based medicine (EviMed) company that is committed to developing and commercializing predictive diagnostics and preventive drugs and therapies for critical disease states.
Evidence-based medicine is the treatment of diseases prior to their full manifestation, with the goal of reducing their occurrence and preventing disease progression by early identification of patients with increased risk factors.
Drawing on long experience in developing diagnostic assays and antibodies for disease detection and treatment, Signet's mission is to create novel diagnostics and drugs for patients at risk for cancer, sepsis and renal failure (SARF), neurodegenerative diseases including Alzheimer's, Parkinson's and Huntington's, and prion diseases such as "Mad Cow" and vCJD.
In addition to diagnostics, drugs and therapies, Signet offers a complete product line of over 800 manufactured antibodies, ELISA kits, detection products and accessories in an FDA registered facility. Signet products are available online, at http://www.signetlabs.com/.
Contact Information
Ms. Terri Daly
Marketing Communications
Signet Laboratories, Inc.
180 Rustcraft Road
Dedham, MA 02026
Phone: 781.915.1404
Fax: 781.461.2456
tdaly@signetlabs.com
Signet Laboratories, Inc.